Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Weckesser

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Journal of Alzheimer'S Disease : JAD|April 5, 2018
Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal DementiaJulia Krämer, Gero Lueg, Patrick Schiffler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2020
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysisRobert Seifert, Katharina Kessel, Katrin Schlack, et al.
World Neurosurgery|August 4, 2020
Somatostatin Receptor-Targeted Radioligand Therapy in Head and Neck ParagangliomaWolfgang Roll, Michael Müther, Peter B Sporns, et al.
Pediatric Blood & Cancer|November 12, 2020
Pain in survivors of Ewing sarcoma: Prevalence, associated factors and prediction of recurrenceMelina Heinemann, Christiane Hoffmann, Jendrik Hardes, et al.
Inflammatory Bowel Diseases|February 24, 2012
Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluationFrank Lenze, Johannes Wessling, Janbernd Bremer, et al.
Molecular Imaging|June 28, 2017
Multimodal Imaging of Patients With Gliomas Confirms <sup>11</sup>C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After TherapyKai R Laukamp, Florian Lindemann, Matthias Weckesser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 22, 2013
Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammationDominik Bettenworth, Stefan Reuter, Sven Hermann, et al.
Leukemia|October 14, 2022
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trialRobert Seifert, David Kersting, Christoph Rischpler, et al.
Pediatric Blood & Cancer|February 27, 2018
Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?Melina Heinemann, Andreas Ranft, Thorsten Langer, et al.
Neuro-Oncology|February 13, 2020
TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant gliomaBastian Zinnhardt, Michael Müther, Wolfgang Roll, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Journal of Alzheimer'S Disease : JAD|April 5, 2018
Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal DementiaJulia Krämer, Gero Lueg, Patrick Schiffler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2020
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysisRobert Seifert, Katharina Kessel, Katrin Schlack, et al.
World Neurosurgery|August 4, 2020
Somatostatin Receptor-Targeted Radioligand Therapy in Head and Neck ParagangliomaWolfgang Roll, Michael Müther, Peter B Sporns, et al.
Pediatric Blood & Cancer|November 12, 2020
Pain in survivors of Ewing sarcoma: Prevalence, associated factors and prediction of recurrenceMelina Heinemann, Christiane Hoffmann, Jendrik Hardes, et al.
Inflammatory Bowel Diseases|February 24, 2012
Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluationFrank Lenze, Johannes Wessling, Janbernd Bremer, et al.
Molecular Imaging|June 28, 2017
Multimodal Imaging of Patients With Gliomas Confirms <sup>11</sup>C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After TherapyKai R Laukamp, Florian Lindemann, Matthias Weckesser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 22, 2013
Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammationDominik Bettenworth, Stefan Reuter, Sven Hermann, et al.
Leukemia|October 14, 2022
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trialRobert Seifert, David Kersting, Christoph Rischpler, et al.
Pediatric Blood & Cancer|February 27, 2018
Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?Melina Heinemann, Andreas Ranft, Thorsten Langer, et al.
Neuro-Oncology|February 13, 2020
TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant gliomaBastian Zinnhardt, Michael Müther, Wolfgang Roll, et al.
Pageof 10